RESIST Provides the Scientific Foundation for a Potential PSC Therapy The currently incurable liver disease "primary sclerosing cholangitis (PSC)" affects approximately one in 10,000 people in Germany. Characterized by chronic inflammation of the bile ducts, PSC frequently leads to severe complications, including the need for liver transplantation. To date, [...]

Big data study reveals an association with a molecular state of immune cells How Long COVID develops is still poorly understood. A recent study led by Prof. Yang Li at the Centre for Individualised Infection Medicine (CiiM) now provides new insights into potential molecular mechanisms underlying the condition. Yang [...]

At MHH, a Fulbright scholar is combining engineering and immunology to improve wound treatment. Chronic wounds often cause great distress to those affected, as they heal very poorly, are painful, and restrict movement. At Hannover Medical School (MHH), Fulbright scholar Samuel Sung from the USA is now spending a [...]

Here is the new RESIST newsletter! In this newsletter, we report on the RESIST symposium (pages 2 and 3), exciting research results (from page 6), new members and students (7 and 10).  You can join us as we explain to school pupils, patients and interested guests at the MHH [...]